当前位置: 首页 >> 检索结果
141. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension: A Scientific Statement from the American Heart Association and the American College of Cardiology.
作者: Henry R Black.;Domenic Sica.;Keith Ferdinand.;William B White.; .
来源: Circulation. 2015年132卷22期e298-302页 142. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
作者: Robert O Bonow.;Rick A Nishimura.;Paul D Thompson.;James E Udelson.; .
来源: Circulation. 2015年132卷22期e292-7页 143. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.
作者: George F Van Hare.;Michael J Ackerman.;Juli-Anne K Evangelista.;Richard J Kovacs.;Robert J Myerburg.;Keri M Shafer.;Carole A Warnes.;Reginald L Washington.; .
来源: Circulation. 2015年132卷22期e281-91页 144. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
作者: Barry J Maron.;James E Udelson.;Robert O Bonow.;Rick A Nishimura.;Michael J Ackerman.;N A Mark Estes.;Leslie T Cooper.;Mark S Link.;Martin S Maron.; .
来源: Circulation. 2015年132卷22期e273-80页 145. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact: A Scientific Statement From the American Heart Association and American College of Cardiology.
作者: Benjamin D Levine.;Aaron L Baggish.;Richard J Kovacs.;Mark S Link.;Martin S Maron.;Jere H Mitchell.; .
来源: Circulation. 2015年132卷22期e262-6页 146. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology.147. Asymptomatic Takayasu Aortitis Complicated by Type B Dissection.
作者: Andrea Barison.;Cinzia Nugara.;Valentina Barletta.;Giancarlo Todiere.;Elena Montebello.;Serena Rossi.;Anna Terrizzi.;Antonio Tavoni.;Giovanni Donato Aquaro.
来源: Circulation. 2015年132卷22期e254-5页 151. Retrospective Analysis of Long-Term Outcomes After Combat Injury: A Hidden Cost of War.
作者: Ian J Stewart.;Jonathan A Sosnov.;Jeffrey T Howard.;Jean A Orman.;Raymond Fang.;Benjamin D Morrow.;David H Zonies.;Mary Bollinger.;Caroline Tuman.;Brett A Freedman.;Kevin K Chung.
来源: Circulation. 2015年132卷22期2126-33页
During the conflicts in Iraq and Afghanistan, 52,087 service members have been wounded in combat. The long-term sequelae of these injuries have not been carefully examined. We sought to determine the relation between markers of injury severity and the subsequent development of hypertension, coronary artery disease, diabetes mellitus, and chronic kidney disease.
153. Association of Hospital and Physician Characteristics and Care Processes With Racial Disparities in Procedural Outcomes Among Contemporary Patients Undergoing Coronary Artery Bypass Grafting Surgery.
作者: Rajendra H Mehta.;David M Shahian.;Shubin Sheng.;Sean M O'Brien.;Fred H Edwards.;Jeffery P Jacobs.;Eric D Peterson.; .; .
来源: Circulation. 2016年133卷2期124-30页
Previous studies have reported that black patients undergoing coronary artery bypass surgery had worse outcomes than white patients, even after accounting for patient factors. The degree to which clinician, hospital, and care factors account for these outcome differences remains unclear.
154. Stroke in Adults With Congenital Heart Disease: Incidence, Cumulative Risk, and Predictors.
作者: Jonas Lanz.;James M Brophy.;Judith Therrien.;Mohammed Kaouache.;Liming Guo.;Ariane J Marelli.
来源: Circulation. 2015年132卷25期2385-94页
Stroke is an important cause of morbidity and mortality, although there is a lack of comprehensive data on its incidence, cumulative risk, and predictors in patients with adult congenital heart disease.
157. Response to Letter Regarding Article, "Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet".
作者: Amna Abderrazak.;Dominique Couchie.;Dler Faieeq Darweesh Mahmood.;Rima Elhage.;Cécile Vindis.;Muriel Laffargue.;Véronique Matéo.;Berthold Büchele.;Monica Rubio Ayala.;Menna El Gaafary.;Tatiana Syrovets.;Mohamed-Naceur Slimane.;Bertrand Friguet.;Tamas Fulop.;Thomas Simmet.;Khadija El Hadri.;Mustapha Rouis.
来源: Circulation. 2015年132卷21期e250-1页 158. Letter by Karasawa and Takahashi Regarding Article, "Anti-inflammatory and Antiatherogenic Effects of the Inflammasome NLRP3 Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet".159. Letter by Abu Daya et al Regarding Article, "Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction, Contributions of Collagen and Titin". |